The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
NCT04397107
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
IL-2
Sponsor
The First Hospital of Jilin University